Cleared Traditional

K780812 - ESOPHAGEAL MOTILITY SYSTEM - MODEL 3330 (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K780812 · Honeywell, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1978
Decision
27d
Days
Class 2
Risk

K780812 is an FDA 510(k) clearance for the ESOPHAGEAL MOTILITY SYSTEM - MODEL 3330. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Honeywell, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 13, 1978 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Honeywell, Inc. devices

Submission Details

510(k) Number K780812 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 1978
Decision Date June 13, 1978
Days to Decision 27 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
103d faster than avg
Panel avg: 130d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 68
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K780812.
mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001)
K252605 · Medspira, LLC · Dec 2025
Solar Compact (G4-1)
K240007 · Laborie Medical Technologies, Corp. · May 2024
EndoflipTM 300 System
K231861 · Covidien, LLC · Jul 2023
EndoflipTM 300
K223705 · Covidien, LLC · Apr 2023
Transit-Pellets
K222000 · Medifactia AB · Jan 2023